Home > News > Q10: Stuart Hendry, CEO at Sphere Medical
September 5th, 2007
Q10: Stuart Hendry, CEO at Sphere Medical
Abstract:
Sphere, which was founded in 2002, is combining its patented microtechnology and nanotechnology to develop unique dice-sized microanalysers capable of measuring several key compounds such as, glucose, blood gases and drugs, simultaneously at low cost. Mortality in critical care remains unacceptably high, with associated costs of £billions annually. Real time measurement of drugs and physiological parameters, facilitating tight control of therapy, has been shown to dramatically improve patient outcomes, saving lives and money. Unfortunately, cost effective products to achieve this ideal are not currently available.
Source:
businessweekly.co.uk
Bookmark:
| Related News Press |
Nanomedicine
Diamond glitter: A play of colors with artificial DNA crystals May 17th, 2024
Advances in priming B cell immunity against HIV pave the way to future HIV vaccines, shows quartet of new studies May 17th, 2024
New micromaterial releases nanoparticles that selectively destroy cancer cells April 5th, 2024
Interviews/Book Reviews/Essays/Reports/Podcasts/Journals/White papers/Posters
Gene therapy relieves back pain, repairs damaged disc in mice: Study suggests nanocarriers loaded with DNA could replace opioids May 17th, 2024
Oscillating paramagnetic Meissner effect and Berezinskii-Kosterlitz-Thouless transition in cuprate superconductor May 17th, 2024
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||